
TSE:DOL
This summary was created by AI, based on 38 opinions in the last 12 months.
Dollarama Inc. (DOL-T) has been recognized as a strong growth story, particularly as consumers tend to trade down during tough economic times, which bodes well for dollar stores like DOL. Despite its impressive growth and expansion into international markets such as Latin America and Australia, a significant concern remains the high valuation, with many analysts noting a price-to-earnings (PE) ratio that approaches or exceeds 40x. Expert reviews highlight mixed feelings regarding the company's future growth potential, particularly as the Canadian market shows signs of saturation. Although there are arguments for its robust business model and consistent earnings growth, valuation concerns often overshadow these positives, leading many to advise caution or to wait for a more favorable buying opportunity. Overall, while DOL is viewed as a well-managed and valued brand in the retail sector, its high valuation and potential slowing growth in Canada create a nuanced investment outlook.
It is a great, great company. A truly Canadian success story. He is wary of the valuation at close to 30 times earnings recently. Grocers are half that. It has pretty good visibility. They think they can get to 1700 stores before the market is saturated. The next leg of growth is Latin America. They grow dividends and buy back stock with very little competition. He would buy on a pull back.
The chart makes this a rock star, although it has paused recently. This business is a pure momentum growth stock that always trades at a rich multiple – it is always expensive. He tends to stay away from these stocks as the risk is too great of buying at the wrong time. It only pays less than 0.5% yield.
It's always been expensive, but he bought after a bad report three years ago. It's trading at 25x next year's earnings, so still pricey, but they are great operators. Strong same-store sales growth and they are opening more stores. There's room to grow. Recently, the stock pulled back and has been flat for the year, so take advantage of this lull. Their Q1 earnings report blamed the bad weather. Sales may make up for that loss in Q2.
It's looked expensive for a number of years and now looks cheap--but it just did a stock split. If they do an earnings miss, they will dip 8-10%. That's an opportunity. DOL carries a little higher risk than normal. It's expensive, though well-run. Quebec is the last bastion of growth for them. The U.S. has too much competition for them. In 5-10 years this will run into growth problems.
Only 27 Canadian companies match his screen. This one met the 30% ROE hurdle. He still sees a good runway for growth and likes the growth prospects in South America, where they have a store count of 101 locations now in a minority position with an option to become the majority holder. Yield 0.3%. (Analysts’ price target is $55.94)
Had a good day today, but earnings lately a bit soft. Started taking a position when it was basing in April/May, and held a full position by early June. Market liked that they’re going to focus much more on Latin area expansion. Likely to become a majority shareholder in Dollar City. Increased both their eps guidance for 2019 and 2020, as well as their share buyback allowance. Drug capx marries well with the technical bottom you can see. (Analysts’ price target is $167.50.)
He really likes it as a company. He has not owned it in a while but it was a mistake. It was always out of his price range. He has a hard time with the valuation.